Sumatriptan: Vasoactive effect on human durai vessels, demonstrated by subselective angiography

Cephalalgia

Volumn 16, Issue 4, 1996, Pages 224-230

  Henkes, H ^a   May, A ^b   Kuhne D ^a   Berg Dammer, E ^a   Diener, H C ^b  

^a ALFRIED KRUPP KRANKENHAUS   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

SUMATRIPTAN;

ADULT; ANGIOGRAPHY; ARTERIOVENOUS MALFORMATION; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; SUBCUTANEOUS DRUG ADMINISTRATION; VASOCONSTRICTION;

ADULT; CEREBRAL ANGIOGRAPHY; FEMALE; HUMANS; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; MALE; MENINGEAL ARTERIES; MIDDLE AGED; SUMATRIPTAN;

EID: 0029952269     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.1996.1604224.x     Document Type: Article

References (27)

1. Humphrey PPA, Feniuk W, Motevalian M, Parsons AA, Whalley ET. The vasoconstrictor action of sumatriptan on human isolated dura mater. In: Fozard JR, Saxena PR, editors. Serotonin: molecular biology, receptors and functional effects. Basel: Birkhäuser, 1991:420-9
2. Jansen I, Edvinson L, Mortensens A, Olesen J. Sumatriptan is a potent vasoconstrictor in human durai arteries via a 5HT1-like receptor. Cephalalgia 1992;12:202-5
3. Diener HC, Limmroth V, May A, Laurich F, Auerbach P, Wosnitza G, Eppe T. Changes of cerebral blood flow velocity after treatment of migraine with sumatriptan or placebo. Cephalalgia 1993;13:14
4. Caekebeke JF, Ferrari MD, Zwetsloot CP, Jansen J, Saxena PR. Antimigraine drug sumatriptan increases blood flow velocity in large cerebral arteries during migraine attacks. Neurology 1992;42:1522-6
5. Thie A, Carvajal-Lizano M, Schlichting U, Spitzer K, Kunze K. Multimodal tests of cerebrovascular reactivity in migraine: a transcranial Doppler study. J Neurol 1992;239:338-42
6. Lauritzen M, Olesen J. Regional cerebral blood flow during migraine attacks by Xenon-133 inhalation and emission tomography. Brain 1984;107:447-61
7. Totaro R, Matteis G de, Marini C, Prencipe M. Cerebral blood flow in migraine with aura: a transcranial Doppler sonography study. Headache 1992;32:446-51
8. Zwetsloot CP, Caekebeke JFV, Jansen JC, Odink J, Ferrari MD. Blood flow velocities in the vertebrobasilar system during migraine attacks - a transcranial Doppler study. Cephalalgia 1992;12:29-32
9. Zwetsloot CP, Caekebeke JFV, Ferrari MD. Lack of asymmetry of middle cerebral artery blood velocity in unilateral migraine. Stroke 1993;24:1335-8
10. 99mTc-HMPAO SPECT in migraine attacks without aura and effect of sumatriptan on regional cerebral blood flow. In: Olesen J, editor. Migraine and other headaches: the vascular mechanisms. New York: Raven Press, 1991:245-8
11. Ferrari MD, Haan J, Blokland JA, Arndt JW, Minnee P, Zwinderman AH, Pauwels EK, Saxena PR. Cerebral blood flow during migraine attacks without aura and effect of sumatriptan. Arch Neurol 1995;52:135-9
12. Scott AK. Sumatriptan clinical pharmacokinetics. Clin Pharmacokinet 1994;27:337-44
13. MacLean MR, Clayton RA, Hillis SW, McIntyre PD, Peacock AJ, Templeton AG. 5-HT1-receptor-mediated vasoconstriction in bovine isolated pulmonary arteries: influences of vascular endothelium and tone. Pulm Pharmacol 1994;7:65-72
14. Villalon CM, Terron JA. The 5-HT1-like receptor mediating the increase in canine external carotid blood flow: close resemblance to the 5-HT1D subtype. Br J Pharmacol 1994;113:13-20
15. Hamel E, Gregoire L, Lau B. 5-HT1 receptors mediating contraction in bovine cerebral arteries: a model for human cerebrovascular "5-HT1D beta" receptors. Eur J Pharmacol 1993;242:75-82
16. Kobari M, Fukuuchi Y, Tomita M, Tanahashi N, Konno S, Takeda H. Effects of sumatriptan on the cerebral intraparenchymal microcirculation in the cat. Br J Pharmacol 1993; 110:1145-8
17. Oliver DW, Dormehl IC, Hugo N. Effect of sumatriptan on cerebral blood flow in the baboon model. Arneimittelforschung 1994;44:925-8
18. Humphrey PA, Connor HE, Stubbs CM, Feniuk W. Effect of sumatriptan on pial vessel diameter in vivo. In: Olesen J, editor. Migraine and other headaches: the vascular mechanisms. New York: Raven Press, 1991;335-8
19. Friberg L, Olesen J, Iversen HK, Sperling B. Migraine pain associated with middle cerebral dilatation: reversal by sumatriptan. Lancet 1991;338:13-7
20. MacIntyre PD, Bhargava B, Hogg KJ, Gemmill JD, Hillis WS. Effect of subcutaneous sumatriptan, a selective 5HT1 agonist, on the systemic, pulmonary, and coronary circulation. Circulation 1993;87:401-5
21. Visser WH, Vielvoye GJ, Ferrari MD. Role of meningeal blood vessels in migraine headache and effect of sumatriptan. Cephalalgia 1993;13: Suppl 13:62
22. Buzzi MG, Moskowitz MA. The trigeminovascular system and migraine. Pathol Biol 1992;40:313-7
23. Moskowitz MA, Buzzi MG, Sakas DE, Linnik MD. Pain mechanisms underlying vascular headaches. Rev Neurol 1989;145:181-93
24. Moskowitz MA. Basic mechanisms in vascular headache. Neurol Clin 1990;8:801-15
25. Moskowitz MA. The visceral organ brain: implications for the pathophysiology of vascular headache. Neurology 1991;41: 182-6
26. Jansen I, Olesen J, Edvinsson L. 5-HT receptor characterization of human cerebral, middle meningeal and temporal arteries: regional differences. Acta Physiol Scand 1993;147:141-50
27. Bates D, Ashford E, Dawson R, Ensink FBM, Gilhus NE, Olesen J, Pilgrim AJ, Shevlin P. Subcutaneous sumatriptan during the migraine aura. Neurology 1994;44:1587-92